Search results
Results from the WOW.Com Content Network
Hydroxychloroquine, sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth, often in the form of hydroxychloroquine sulfate. [3]
“In individuals affected by malaria, hydroxychloroquine acts within red blood cells to kill the malarial parasites that cause the disease,” says Kelly Johnson-Arbor, M.D., a toxicologist at ...
Other causes can include acid reflux, asthma, allergies, or other chronic medical conditions, adds Richard Watkins, M.D., an infectious disease physician and professor of medicine at the Northeast ...
A World Health Organization infographic that states that hydroxychloroquine does not prevent illness or death from COVID-19. Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. [1] Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. [2]
Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. [65] Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. [66] Neither drug has been useful to prevent or treat SARS-CoV-2 infection.
Three common clusters of symptoms have been identified: a respiratory symptom cluster with cough, sputum, shortness of breath, and fever; a musculoskeletal symptom cluster with muscle and joint pain, headache, and fatigue; and a cluster of digestive symptoms with abdominal pain, vomiting, and diarrhea. [5]
Hydroxychloroquine is recommended as first-line therapy to treat all cSLE patients unless they have contraindications to taking it. Hydroxychloroquine is an antimalarial drug that also reduces the fatigue, mucosal, and cutaneous symptoms, alopecia, disease flares, and blood lipid levels in cSLE.
Hydroxychloroquine is an FDA-approved antimalarial used for constitutional, cutaneous, and articular manifestations. Hydroxychloroquine has relatively few side effects, and there is evidence that it improves survival among people who have SLE. [120] Cyclophosphamide is used for severe glomerulonephritis or other organ-damaging complications.